The QUAZAR AML-001 maintenance trial: Results of a phase III international, randomized, double-blind, placebo-controlled study of oral CC-486 in patients with Acute Myeloid Leukemia (AML) in first remission H. Doehner,A. H. Wei,C. Pocock,P. Montesinos,H. Dombret,F. Ravandi,H. Sayar,J. H. Jang,K. Porkka,D. Selleslag,I. Sandhu,M. Turgut, V. Giai,Y. Ofran,M. K. Cakar,A. Botelho de Sousa,J. Rybka,C. Frairia,L. Borin, G. Beltrami,J. Cermak,M. Pfeilstoecker, F. Thol,G. Feldmann,G. J. Ossenkoppele,I. La Torre,B. Skikne,K. Kumar,Q. Dong, C. L. Beach,G. J. RobozONCOLOGY RESEARCH AND TREATMENT（2020）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
